Medifast, Inc. short interest in 2018
In 2018, Medifast, Inc.'s disclosed short interest ran from 2.51% of shares outstanding on 12 Jan 2018 to 11.79% on 31 Dec 2018, a change of +9.28 percentage points. The year's high was 11.79% on 31 Dec 2018 and its low 2.00% on 28 Feb 2018, averaging 4.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.60 days on 31 Dec 2018. Full history: Medifast, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 2.51% (12 Jan 2018)
- End of year
- 11.79% (31 Dec 2018)
- Change
- +9.28 pp
- High
- 11.79% (31 Dec 2018)
- Low
- 2.00% (28 Feb 2018)
- Average
- 4.50%
- Highest days to cover
- 4.60 (31 Dec 2018)
- SEC filings marked
- 8
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 2.51% | 3.22 | |
| 31 Jan 2018 | 2.30% | 3.60 | |
| 15 Feb 2018 | 2.04% | 2.46 | |
| 28 Feb 2018 | 2.00% | 3.05 | |
| 15 Mar 2018 | 2.67% | 1.09 | results (8-K) |
| 29 Mar 2018 | 2.91% | 1.65 | 10-K filed |
| 13 Apr 2018 | 3.56% | 2.41 | |
| 30 Apr 2018 | 4.22% | 3.26 | |
| 15 May 2018 | 4.30% | 2.07 | results (8-K), 10-Q filed |
| 31 May 2018 | 4.20% | 3.31 | |
| 15 Jun 2018 | 4.18% | 2.57 | |
| 29 Jun 2018 | 3.88% | 1.69 | |
| 13 Jul 2018 | 3.87% | 2.89 | |
| 31 Jul 2018 | 3.77% | 2.97 | |
| 15 Aug 2018 | 2.79% | 1.02 | results (8-K), 10-Q filed |
| 31 Aug 2018 | 3.32% | 2.62 | |
| 14 Sep 2018 | 3.50% | 1.74 | |
| 28 Sep 2018 | 6.31% | 1.34 | |
| 15 Oct 2018 | 6.20% | 3.13 | |
| 31 Oct 2018 | 6.29% | 3.56 | |
| 15 Nov 2018 | 5.35% | 1.71 | results (8-K), 10-Q filed |
| 30 Nov 2018 | 6.90% | 3.01 | |
| 14 Dec 2018 | 9.04% | 3.72 | |
| 31 Dec 2018 | 11.79% | 4.60 |
See also: Medifast, Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.